TS Financial Group (TSFG)’s Definium Therapeutics DFTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$0 Hold
6
﹤0.01% 898
2026
Q1
$0 Hold
6
﹤0.01% 860
2025
Q4
$0 Hold
6
﹤0.01% 859
2025
Q3
$0 Hold
6
﹤0.01% 878
2025
Q2
$0 Sell
6
-18
-75% -$118 ﹤0.01% 851
2025
Q1
$0 Hold
24
﹤0.01% 839
2024
Q4
$0 Hold
24
﹤0.01% 789
2024
Q3
$0 Hold
24
﹤0.01% 823
2024
Q2
$0 Hold
24
﹤0.01% 788
2024
Q1
$0 Hold
24
﹤0.01% 863
2023
Q4
$0 Hold
24
﹤0.01% 980
2023
Q3
$1K Hold
24
﹤0.01% 977
2023
Q2
$0 Hold
24
﹤0.01% 1033
2023
Q1
$0 Hold
24
﹤0.01% 987
2022
Q4
$0 Hold
24
﹤0.01% 1005
2022
Q3
$0 Sell
24
-1
-4% -$10 ﹤0.01% 1008
2022
Q2
$0 Buy
+25
New +$316 ﹤0.01% 1035
2022
Q1
Sell
-25
Closed -$1K 973
2021
Q4
$1K Hold
25
﹤0.01% 838
2021
Q3
$1K Buy
25
+6
+32% +$259 ﹤0.01% 822
2021
Q2
$1K Buy
+19
New +$997 ﹤0.01% 828

Other funds holding DFTX

TS Financial Group (TSFG)'s DFTX Position: Q2 2026 in Review

TS Financial Group (TSFG) held its Definium Therapeutics (DFTX) position steady in Q2 2026 at 6 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #898.

TS Financial Group (TSFG) first reported a position in DFTX in Q2 2021 and has held it in 20 quarters since. The position peaked at $1K in Q3 2023. 74 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • TS Financial Group (TSFG) held 6 shares of Definium Therapeutics worth $0 as of Q2 2026.
  • TS Financial Group (TSFG) left its Definium Therapeutics share count unchanged in Q2 2026.
  • Definium Therapeutics made up ﹤0.01% of TS Financial Group (TSFG)'s portfolio in Q2 2026, its #898 holding.
  • TS Financial Group (TSFG) first reported a position in Definium Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • TS Financial Group (TSFG)'s Definium Therapeutics position peaked at $1K in Q3 2023.
  • 74 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on TS Financial Group (TSFG)'s 13F filing for Q2 2026, filed 23 Jul 2026.